Skip to content

Effect of Dough Fermentation Time of Bread on the Glycaemic Index

Effect of Dough Fermentation Time of Bread on the Glycaemic Index

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02570880
Acronym
SLOWBREAD
Enrollment
15
Registered
2015-10-07
Start date
2015-10-31
Completion date
2015-12-31
Last updated
2015-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycemic Index (MeSH T483740)

Brief summary

This study evaluates the impact of dough fermentation times on the glycaemic index of the ensuing breads.

Detailed description

The worldwide prevalence for non-communicable diseases (NCD) is increasing, nutrition is considered to be one of the main modifiable risk factors. An unhealthy diet leads to obesity, which is a further risk factor for NCDs. Excessive carbohydrates but also the nutritional quality of carbohydrates, can be elements defining unhealthy diets. The nutritional quality of carbohydrates can be expressed as the glycaemic index. Fermentation time of bread dough could affect the ensuing bread quality to such an extent that it influences ist glycaemic index. If this hypothesis is confirmed, the process of breadmaking could be optimized in order to offer healthier bread varieties on the market.

Interventions

OTHERglycemic index (glucose-solution, bread samples)

All participants will test 2 breads, prepared with different fermentation times of dough, both breads will be tested in duplicate. Methode: International Organization for Standardization / Final Draft International Standard 26642, Food products - Determination of the glycaemic index (GI) and recommendation for food classification

Sponsors

Beatrice Baumer
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* no known food allergy or intolerance; * no medications known to affect glucose tolerance (excluding oral contraceptives) * stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable.

Exclusion criteria

* a known history of diabetes mellitus or the use of antihyperglycaemic drugs or insulin to treat diabetes and related conditions; * a major medical or surgical event requiring hospitalization within the preceding 3 months; * the presence of disease or drug(s) which influence digestion and absorption of nutrients; * the use of steroids, protease inhibitors or antipsychotics * pregnancy / breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Change in postprandial glycemia: Glucose in capillary blood samples over 2 hours (blood samples every 15 minutes), after oral intake of bread samples or glucose-solution (reference)2 hours for each sample, 7 samples total, on non consecutive days, over 4 weeksa drop of capillary blood will be taken every 15 minutes after ingestion of a bread sample containing 50 g of available carbohydrates

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026